114 related articles for article (PubMed ID: 30315111)
1. Electrostatic repulsion causes anticooperative DNA binding between tumor suppressor ETS transcription factors and JUN-FOS at composite DNA sites.
Madison BJ; Clark KA; Bhachech N; Hollenhorst PC; Graves BJ; Currie SL
J Biol Chem; 2018 Nov; 293(48):18624-18635. PubMed ID: 30315111
[TBL] [Abstract][Full Text] [Related]
2. Dynamics of Fos-Jun-NFAT1 complexes.
Ramirez-Carrozzi VR; Kerppola TK
Proc Natl Acad Sci U S A; 2001 Apr; 98(9):4893-8. PubMed ID: 11320240
[TBL] [Abstract][Full Text] [Related]
3. Coordinate regulation of ELF5 and EHF at the chr11p13 CF modifier region.
Swahn H; Sabith Ebron J; Lamar KM; Yin S; Kerschner JL; NandyMazumdar M; Coppola C; Mendenhall EM; Leir SH; Harris A
J Cell Mol Med; 2019 Nov; 23(11):7726-7740. PubMed ID: 31557407
[TBL] [Abstract][Full Text] [Related]
4. DNA binding by the ETS protein TEL (ETV6) is regulated by autoinhibition and self-association.
Green SM; Coyne HJ; McIntosh LP; Graves BJ
J Biol Chem; 2010 Jun; 285(24):18496-504. PubMed ID: 20400516
[TBL] [Abstract][Full Text] [Related]
5. Targeting the DNA-binding activity of the human ERG transcription factor using new heterocyclic dithiophene diamidines.
Nhili R; Peixoto P; Depauw S; Flajollet S; Dezitter X; Munde MM; Ismail MA; Kumar A; Farahat AA; Stephens CE; Duterque-Coquillaud M; David Wilson W; Boykin DW; David-Cordonnier MH
Nucleic Acids Res; 2013 Jan; 41(1):125-38. PubMed ID: 23093599
[TBL] [Abstract][Full Text] [Related]
6. Transcription factor EHF interacting with coactivator AJUBA aggravates malignancy and acts as a therapeutic target for gastroesophageal adenocarcinoma.
Peng L; Jiang Y; Chen H; Wang Y; Lan Q; Chen S; Huang Z; Zhang J; Tian D; Qiu Y; Cai D; Peng J; Lu D; Yuan X; Yang X; Yin D
Acta Pharm Sin B; 2024 May; 14(5):2119-2136. PubMed ID: 38799645
[TBL] [Abstract][Full Text] [Related]
7. Purification, crystallization and preliminary X-ray crystallographic analysis of the ETS domain of human Ergp55 in complex with the cfos promoter DNA sequence.
Gangwar SP; Meena SR; Saxena AK
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2012 Nov; 68(Pt 11):1333-6. PubMed ID: 23143243
[TBL] [Abstract][Full Text] [Related]
8. Transcription factor co-localization patterns affect human cell type-specific gene expression.
Wang D; Rendon A; Ouwehand W; Wernisch L
BMC Genomics; 2012 Jun; 13():263. PubMed ID: 22721266
[TBL] [Abstract][Full Text] [Related]
9. Structural modeling and DNA binding autoinhibition analysis of Ergp55, a critical transcription factor in prostate cancer.
Gangwar SP; Dey S; Saxena AK
PLoS One; 2012; 7(6):e39850. PubMed ID: 22761914
[TBL] [Abstract][Full Text] [Related]
10. Human ERG oncoprotein represses
Bharti M; Bajpai A; Rautela U; Manzar N; Ateeq B; Sinha P
Proc Natl Acad Sci U S A; 2023 Jan; 120(2):e2211189119. PubMed ID: 36595681
[TBL] [Abstract][Full Text] [Related]
11. Transcription factor exchange enables prolonged transcriptional bursts.
Pomp W; Meeussen JVW; Lenstra TL
Mol Cell; 2024 Mar; 84(6):1036-1048.e9. PubMed ID: 38377994
[TBL] [Abstract][Full Text] [Related]
12. Polymorphism, Genetic Effect, and Association with Egg-Laying Performance of Chahua Chickens Matrix Metalloproteinases 13 Promoter.
Du Y; Cao C; Liu Y; Zi X; He Y; Shi H; Zhao J; Ge C; Wang K
Genes (Basel); 2023 Jun; 14(7):. PubMed ID: 37510257
[TBL] [Abstract][Full Text] [Related]
13. Sci-Seq of Human Fetal Salivary Tissue Introduces Human Transcriptional Paradigms and a Novel Cell Population.
Ehnes DD; Alghadeer A; Hanson-Drury S; Zhao YT; Tilmes G; Mathieu J; Ruohola-Baker H
Front Dent Med; 2022; 3():. PubMed ID: 36540608
[TBL] [Abstract][Full Text] [Related]
14. ESE3-positive PSCs drive pancreatic cancer fibrosis, chemoresistance and poor prognosis via tumour-stromal IL-1β/NF-κB/ESE3 signalling axis.
Zhao T; Xiao D; Jin F; Sun X; Yu J; Wang H; Liu J; Cai W; Huang C; Wang X; Gao S; Liu Z; Yang S; Gao C; Hao J
Br J Cancer; 2022 Nov; 127(8):1461-1472. PubMed ID: 35986089
[TBL] [Abstract][Full Text] [Related]
15. EHF is a novel regulator of cellular redox metabolism and predicts patient prognosis in HNSCC.
Oyelakin A; Nayak KB; Glathar AR; Gluck C; Wrynn T; Tugores A; Romano RA; Sinha S
NAR Cancer; 2022 Jun; 4(2):zcac017. PubMed ID: 35664541
[TBL] [Abstract][Full Text] [Related]
16. Past, Current, and Future Strategies to Target ERG Fusion-Positive Prostate Cancer.
Lorenzin F; Demichelis F
Cancers (Basel); 2022 Feb; 14(5):. PubMed ID: 35267426
[TBL] [Abstract][Full Text] [Related]
17. Effect of
Tan X; Zheng S; Liu W; Liu Y; Kang Z; Li Z; Li P; Song J; Hou J; Yang B; Han X; Wang F; Jing C; Cao G
Am J Cancer Res; 2021; 11(9):4347-4363. PubMed ID: 34659891
[TBL] [Abstract][Full Text] [Related]
18. Salt bridge dynamics in protein/DNA recognition: a comparative analysis of Elk1 and ETV6.
Vo TD; Schneider AL; Wilson WD; Poon GMK
Phys Chem Chem Phys; 2021 Jun; 23(24):13490-13502. PubMed ID: 34120158
[TBL] [Abstract][Full Text] [Related]
19. Transcription Factor ELF1 Activates MEIS1 Transcription and Then Regulates the GFI1/FBW7 Axis to Promote the Development of Glioma.
Cheng M; Zeng Y; Zhang T; Xu M; Li Z; Wu Y
Mol Ther Nucleic Acids; 2021 Mar; 23():418-430. PubMed ID: 33473327
[TBL] [Abstract][Full Text] [Related]
20. The Transcription Factor ERG Regulates Super-Enhancers Associated With an Endothelial-Specific Gene Expression Program.
Kalna V; Yang Y; Peghaire CR; Frudd K; Hannah R; Shah AV; Osuna Almagro L; Boyle JJ; Göttgens B; Ferrer J; Randi AM; Birdsey GM
Circ Res; 2019 Apr; 124(9):1337-1349. PubMed ID: 30892142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
